期刊文献+

OCTA评价无糖尿病视网膜病变患者黄斑区微循环特征的Meta分析 被引量:3

Meta-analysis of macular microcirculation in patients with no diabetic retinopathy evaluated by OCTA
下载PDF
导出
摘要 目的:采用Meta分析的方法,对光学相干断层扫描血管成像技术(OCTA)测量无糖尿病视网膜病变(NDR)的患者黄斑区的血流密度(VD)及浅层中心凹无血管区(FAZ)面积进行系统评价,探讨糖尿病早期视网膜的微循环特征。方法:在PubMed、Embase、Web of Science、Cochrane Library数据库中全面检索发表于2011-01-01/2021-01-05之间关于OCTA分析NDR患者黄斑区不同区域血流密度的研究。比较NDR组与正常对照组(同期年龄、性别与NDR组患者相匹配的健康人群)在浅层旁中心凹血流密度(spafVD)、浅层中心凹周围血流密度(spefVD)、深层旁中心凹血流密度(dpafVD)、深层中心凹周围血流密度(dpefVD)、浅层FAZ面积、最佳矫正视力(BCVA)。结果:研究纳入文献13篇,共1227眼(正常对照组558眼,NDR组669眼)。Meta分析结果显示:与正常对照组相比,NDR组spafVD(MD=-1.90,95%CI:-2.43~-1.37,P<0.00001)、spefVD(MD=-1.29,95%CI:-2.14~-0.44,P=0.003)、dpafVD(MD=-2.18,95%CI:-2.69~-1.67,P<0.00001)、dpefVD(MD=-2.37,95%CI:-3.27~-1.46,P<0.00001)显著降低,其中dpefVD降低更明显;浅层FAZ面积(MD=0.04,95%CI:0.03~0.06,P<0.00001)增大;两组BCVA比较无差异(MD=0.00,95%CI:-0.01~0.02,P=0.44)。结论:黄斑区深层中心凹周围区毛细血管损伤是糖尿病患者视网膜微循环障碍的最早期表现,也是糖尿病视网膜病变临床随访的关键指标。 ·AIM:Meta-analysis was performed to systematically evaluate the macular vessel density(VD)and foveal avascular zone(FAZ)areas in patients with no diabetic retinopathy(NDR)by using optical coherence tomography angiography(OCTA).This study aimed to investigate the microcirculatory characteristics of the retina in the early stage of diabetes.·METHODS:PubMed,Embase,Web of Science and Cochrane Library databases were searched for publications from 1 January,2011 to 5 January,2021 on OCTA analysis of VD in different regions of the macular area in diabetic patients with NDR.Compare the differences in the superficial parafoveal VD(spafVD),superficial perifoveal VD(spefVD),deep parafoveal VD(dpafVD),deep perifoveal vessel density(dpefVD),superficial FAZ area and best corrected visual acuity(BCVA)between NDR group and the normal control group(healthy population matched for the age at the same time and gender with patients in the NDR group).·RESULTS:Thirteen publications with a total of 1227 eyes(558 eyes in normal control group and 669 eyes in NDR group)were included in the study.Meta-analysis showed that compared with the control group,NDR group displayed a significant decrease in spafVD(MD=-1.90,95%CI:-2.43--1.37,P<0.00001),spefVD(MD=-1.29,95%CI:-2.14--0.44,P=0.003),dpafVD(MD=-2.18,95%CI:-2.69--1.67,P<0.00001)and dpefVD(MD=-2.37,95%CI:-3.27--1.46,P<0.00001),with a more significant reduction in dpefVD,and superficial FAZ area(MD=0.04,95%CI:0.03-0.06,P<0.00001)was increased.There was no difference in BCVA(MD=0.00,95%CI:-0.01-0.02,P=0.44)between the two groups.·CONCLUSION:Capillary injury in the deep perifoveal region of the macular area is the earliest manifestation of retinal microcirculation disturbance in diabetic patients,and is also a key indicator for clinical follow-up of diabetic retinopathy.
作者 刘丹丹 石蕊 何媛 龚小羽 卢瑶 杨洁 Dan-Dan Liu;Rui Shi;Yuan He;Xiao-Yu Gong;Yao Lu;Jie Yang(Xi'an Medical University,Xi'an 710021,Shaanxi Province,China;Department of Ophthalmology,Shaanxi Provincial People's Hospital,Xi'an 710068,Shaanxi Province,China;Department of Ophthalmology,the Second Affiliated Hospital of Xi'an Medical University,Xi'an 710038,Shaanxi Province,China)
出处 《国际眼科杂志》 CAS 北大核心 2022年第9期1511-1516,共6页 International Eye Science
基金 陕西省自然科学基础研究计划项目(No.2022JM-571) 陕西省人民医院2021年科技发展孵化基金项目(No.2021YJY-20)。
关键词 光学相干断层扫描血管成像技术(OCTA) 糖尿病视网膜病变 黄斑 微循环 META分析 optical coherence tomography angiography(OCTA) diabetic retinopathy macula microcirculation Meta-analysis
  • 相关文献

参考文献2

二级参考文献69

  • 1Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalenceof diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14[PMID: 19896746 DOI: 10.1016/j.diabres.2009.10.007].
  • 2World Health Organization. Diabetes Action Now: An Initiativeof the World Health Organization and the International DiabetesFederation. Switzerland: World Health Organization, 2004.
  • 3Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E.Screening and prevention of diabetic blindness. Acta OphthalmolScand 2000; 78: 374-385 [PMID: 10990036 DOI: 10.1034/j.1600-0420.2000.078004374.x].
  • 4Prokofyeva E, Zrenner E. Epidemiology of major eye diseasesleading to blindness in Europe: a literature review. Ophthalmic Res2012; 47: 171-188 [PMID: 22123077 DOI: 10.1159/000329603].
  • 5Hammes HP. Optimal treatment of diabetic retinopathy. Ther AdvEndocrinol Metab 2013; 4: 61-71 [PMID: 23626903 DOI: 10.1177/2042018813477886].
  • 6Deutsche DG. Nationale VersorgungsLeitlinie Typ-2-DiabetesPr-vention und Therapie von Netzhautkomplikationen. Berlin:Bundes-rztekammer (B-K), 2010: 1-42.
  • 7Giani G, Janka HU, Hauner H, Standl E, Schiel R, Neu, A.Epidemiologie und Verlauf des Diabetes mellitus in Deutschland.Evidenzbasierte Leitlinie DDG-Aktualisierung 2004; 5: 1-12.
  • 8Nentwich MM, Ulbig M. Diabetische Retinopathie. DerDiabetologe 2010; 6: 491-502 [DOI: 10.1007/s11428-010-0605-8].
  • 9Kramer CK, Retnakaran R. Concordance of retinopathy andnephropathy over time in Type 1 diabetes: an analysis of data fromthe Diabetes Control and Complications Trial. Diabet Med 2013;30: 1333-1341 [PMID: 23909911 DOI: 10.1111/dme.12296].
  • 10Karlberg C, Falk C, Green A, Sj-lie AK, Grauslund J. Proliferativeretinopathy predicts nephropathy: a 25-year follow-upstudy of type 1 diabetic patients. Acta Diabetol 2012; 49: 263-268[PMID: 21688016 DOI: 10.1007/s00592-011-0304-y].

共引文献77

同被引文献30

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部